未分化甲状腺癌结肠转移:[18F]FDG PET/CT在非典型表现中的价值
本文报道一例伴乳头状成分和BRAF V600E突变的未分化甲状腺癌(ATC)患者,经手术和放疗后无病间期17个月,于结肠脾曲发现病灶并经组织学证实为ATC转移。该病例展示了不常见的转移部位,强调[18F]FDG PET/CT在检测非典型复发中的价值。
要点
- ATC可发生结肠等非典型部位转移,复发监测需警惕。
- [18F]FDG PET/CT有助于检出ATC的非典型复发灶。
- 无病间期17个月后仍出现转移,提示需持续随访。
核心结论
- ATC患者可出现结肠脾曲转移这一非典型部位,[18F]FDG PET/CT在检测此类非典型复发中具有价值。
研究设计与样本
- 本文为单例病例报告,描述一例伴乳头状成分和BRAF V600E突变的ATC患者的诊治经过。
主要发现
- 患者经手术和放疗后无病间期17个月,于结肠脾曲发现病灶,组织学证实为ATC转移。
临床怎么用
- 对ATC随访中怀疑非典型复发时,可考虑[18F]FDG PET/CT协助定位转移灶。
局限性
- 单例病例报告,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Anaplastic thyroid carcinoma (ATC) is an aggressive malignancy associated with poor survival and a metastatic pattern that typically involves the lungs. A patient with ATC harboring a papillary component and a BRAF V600E mutation, with locoregional invasion, was treated with surgery and radiotherapy following detection of residual disease. After a disease-free interval of 17 months, a lesion was identified at the splenic flexure of the colon, which was histologically confirmed as a metastasis from ATC. This case demonstrates an unusual metastatic site and emphasizes the value of [¹⁸F]FDG PET/CT in detecting atypical recurrences.
引用
- Colet MA, Vasquez VC, Jimenez MPP, et al. Colonic metastasis from anaplastic thyroid carcinoma: The value of [18F]FDG PET/CT in an unusual presentation. Eur J Nucl Med Mol Imaging. 2026. PMID: 42782531. doi:10.1007/s00259-026-08193-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。